Most Liquid Health Care Equipment & Services Companies

Cash And Equivalents
Cash And EquivalentsEfficiencyMarket RiskExp Return
1GEHC GE HealthCare Technologies
1.84 B
(0.14)
 3.21 
(0.45)
2AUNA Auna SA
185.25 M
(0.03)
 3.46 
(0.11)
3ASTH Astrana Health
166.87 M
 0.06 
 4.46 
 0.25 
4TALKW Talkspace
108.22 M
(0.02)
 11.72 
(0.20)
5SHLT SHL Telemedicine Ltd
10.91 M
(0.11)
 4.26 
(0.47)
6AMIX Autonomix Medical, Common
10.39 M
(0.12)
 5.23 
(0.64)
7ALGN Align Technology
1.09 B
(0.14)
 2.98 
(0.42)
8PAVMZ PAVmed Series Z
1.13 M
 0.05 
 32.03 
 1.44 
9ISRG Intuitive Surgical
4.32 B
(0.03)
 3.18 
(0.09)
10HOLX Hologic
2.39 B
(0.16)
 1.97 
(0.31)
11INMD InMode
486.39 M
(0.06)
 2.70 
(0.16)
12IART Integra LifeSciences Holdings
451.52 M
(0.09)
 3.55 
(0.33)
13ACCD Accolade
330.63 M
 0.21 
 0.21 
 0.04 
14ICUI ICU Medical
285.59 M
(0.04)
 3.09 
(0.12)
15ACET Adicet Bio
260.64 M
(0.16)
 4.63 
(0.74)
16SGRY Surgery Partners
227.4 M
 0.01 
 3.31 
 0.03 
17INGN Inogen Inc
223.62 M
(0.14)
 3.78 
(0.54)
18SOPH Sophia Genetics SA
216.61 M
(0.02)
 6.57 
(0.12)
19IRTC iRhythm Technologies
204.49 M
 0.04 
 2.70 
 0.11 
20INSP Inspire Medical Systems
196.32 M
(0.08)
 3.25 
(0.26)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes. Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).